Literature DB >> 123545

Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.

A E Eggers, J R Wunderlich.   

Abstract

Spleen cells from mice with progressively-growing methyl-cholanthrene-induced tumors, when immunized in vitro against transplant alloantigens, developed less cytotoxic activity against these antigens as measured by a short-term chromium-release assay than did spleen cells from normal mice. The hyporesponsiveness of spleen cells from the tumor-bearing mice seemed to be due to the presence of suppressor cells which could be removed by nylon-column passage but not by anti-theta treatment and which, in mixture experiments, could inhibit the response of normal spleen cells. The suppression appeared to occur at the sensitization stage and not at the effector stage of the in vitro tests. No evidence was found for mediation of the suppression by soluble factors. These observations emphasize the growing importance of suppressive mechanisms in tumor immune systems.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 123545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.

Authors:  M A Kall; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.

Authors:  G B Faguet
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

3.  Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.

Authors:  G M Taylor; W D Fergusson; R Harris
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

4.  Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.

Authors:  R J North; E S Dye
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

5.  The role of the spleen in tumor bearing host: I. Characterization of spleen cells in tumor-bearing mice.

Authors:  H Yamagishi; T Oka; I Hashimoto; N R Pellis; B D Kahan
Journal:  Jpn J Surg       Date:  1984-01

6.  Studies on the pathogenesis of an immune defect in multiple myeloma.

Authors:  T Paglieroni; M R MacKenzie
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

7.  Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.

Authors:  R E Anderson; S Tokuda; W L Williams; N L Warner
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

8.  Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population.

Authors:  D G Hesse; D J Cole; D E Van Epps; R C Williams
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state.

Authors:  M A Marsili; M K Robinson; G A Truitt; E F Wheelock
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.

Authors:  S M Hillinger; G P Herzig
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.